Coste-efectividad de rosuvastatina frente a atorvastatina, simvastatina pitavastatina, fluvastatina, pravastatina y lovastatina en el tratamiento de pacientes con riesgo cardiovascular moderado, alto o muy alto en España

Authors: Fácila Rubio, Lorenzo; Pintó Sala, Xavier; Cinza Sanjurjo, Sergio; García Goñi, Manuel; Cortés Gil, Xavier; Martí Ragué, Ignasi; Soler Martinez, María; Aceituno Mata, Susana

Journal: Revista Española Economía de la Salud

Year: 2018

Reference: Rev Esp Econ Salud 2018; 13(4):678-691

Outside URL

Subscribe to Outcomes´10

Name *

E-mail *

Todos los campos marcados con un * son obligatorios

Responsible for the data: Outcomes'10, s.l.u., Purpose: Sending commercial communications. Legitimation: Art. 6.1 Consent of the interested party. Recipient: No data is transferred unless expressly authorised. You may exercise your rights on data protection (access, rectification, opposition, deletion, automated decisions, limitation of treatment, portability) by email at dpo@outcomes10.com. Data will be retained for the time necessary to fulfill its purpose and derived responsibilities by current regulations and the deadlines in the applicable regulations on archives and documentation. In any case, you can request the protection of the Spanish Data Protection Agency through its website www.aepd.es/. In addition, you can consult more information on the privacy policy

I have read and accepted the privacy policy